The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Neurogenomics Market Compare Between 2026 And 2030?
The neurogenomics market has seen substantial expansion in recent years. This market is expected to expand from $1.5 billion in 2025 to $1.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.7%. The historical development of the market can be linked to improvements in genomic sequencing technologies, an increase in neuroscience research funding, the rising occurrence of neurological disorders, enhanced access to bioinformatics tools, and a greater number of academic research collaborations.
The neurogenomics market is set for significant expansion over the next few years. It is forecast to achieve a valuation of $2.98 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.7%. This anticipated growth throughout the forecast period can be linked to the increasing integration of genomics within clinical neurology, rising financial commitments to precision neurology, the expansion of cloud-based genomic analytics, a growing demand for customized neurological therapies, and a heightened focus on translational neuroscience research. Prominent trends expected in this period include the increased adoption of next-generation sequencing in neuroscience, a greater use of multi-omics data integration, the rising need for gene expression analysis in neurology, the broadening scope of personalized neurological research, and an intensified focus on data-driven studies of brain disorders.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25845&type=smp
What Major Factors Are Driving The Neurogenomics Market Forward?
The neurogenomics market is anticipated to expand due to the increasing occurrence of neurological disorders. These disorders are defined as health conditions impacting the brain, spinal cord, or nerves, resulting in manifestations like muscle weakness, seizures, discomfort, or problems with cognition. The growing frequency of neurological disorders stems mainly from lifestyle elements including inadequate diet, insufficient physical activity, persistent stress, and heightened exposure to environmental toxins. Neurogenomics offers enhanced insight into the genetic foundations of brain function and its impairments, thereby facilitating the identification of origins, better diagnostic methods, and specific therapies for neurological disorders. As an illustration, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported that in March 2023, around 6.7 million Americans aged 65 and older were suffering from Alzheimer’s dementia, a figure expected to increase to 13.8 million by 2060. Consequently, the growing occurrence of neurological disorders serves as a key impetus for the expansion of the neurogenomics market.
How Is The Neurogenomics Market Segmented Across Different Segment Categories?
The neurogenomics market covered in this report is segmented –
1) By Offering: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Software And Services
2) By Application: Variant Discovery, Research Applications, Target Identification, Transcription Factor Binding Analysis, Functional Studies, Clinical Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Diagnostic Laboratories
Subsegments:
1) By Next-Generation Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, Ribonucleic Acid Sequencing
2) By Polymerase Chain Reaction: Real-Time Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction
3) By Microarray: Deoxyribonucleic Acid Microarray, Ribonucleic Acid Microarray, Protein Microarray
4) By Software And Services: Data Analysis And Interpretation Software, Genomic Data Management Tools, Custom Services, Cloud-Based Platforms And Reporting Tools
Which Trends Are Impacting The Progress Of The Neurogenomics Market?
Leading companies active in the neurogenomics market are concentrating on developing advanced solutions, such as whole genome sequencing platforms, to improve the diagnosis and understanding of complex neurological disorders. Whole genome sequencing platforms are tools utilized to analyze an individual’s complete DNA sequence, assisting in the identification of genetic factors connected to neurological conditions. For example, in April 2023, Centogene N.V., a Germany-based company involved in rare disease diagnosis and research, launched CentoGenome, described as the world’s most comprehensive whole-genome sequencing (WGS) solution for diagnosing rare and neurodegenerative diseases. This platform uses PCR-free technology to enable high-quality, unbiased sequencing across intricate genetic regions. It enhances variant detection through an advanced bioinformatics pipeline and expert interpretation, identifying nearly all disease-causing variants in one test. Additionally, it offers integrated, lifelong diagnostic support, including free variant reclassification and confirmatory testing as new scientific knowledge becomes available.
Which Organizations Play A Role In The Neurogenomics Market Landscape?
Major companies operating in the neurogenomics market are F. Hoffmann-La Roche Limited, Thermo Fisher Scientific Incorporated, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Myriad Genetics Inc., GeneDx LLC, Fulgent Genetics Inc., Oxford Nanopore Technologies Plc, PacBio, MedGenome Labs Ltd., MGI Tech Co. Ltd., Centogene N.V., Variantyx Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Roche Diagnostics GmbH, Illumina Cambridge Ltd.
Get The Full Neurogenomics Market Report:
https://www.thebusinessresearchcompany.com/report/neurogenomics-global-market-report
Which Region Leads The Neurogenomics Market In Overall Market Size?
North America was the largest region in the neurogenomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Neurogenomics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/neurogenomics-global-market-report
Browse Through More Reports Similar to the Global Neurogenomics Market 2026, By The Business Research Company
Genetic Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Prenatal And Newborn Genetic Testing Market Report
Dna Testing Market Report
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model